New review: secretin does not improve symptoms of autism (extract)

From Volume 3 Number 12

WESTMEAD, Australia: The intestinal hormone secretin, considered by some to be a promising drug in the treatment of autism, does not improve the symptoms and should not be used to treat the disorder, according to a new review of studies.
       After analysing data from 14 high-quality studies involving 618 patients with autistic spectrum disorders, Dr Katrina Williams of the Children's Hospital at Westmead, Australia, and colleagues found no evidence that doses of intravenous secretin improve the social, behavioural or communication problems associated with autism … 

To read the entire article you need to order this back issue

Search this site

Google Groups Beta
Looking Up
Visit this group

BACK ISSUE CONTENTS AND FRONT COVERS
VOLUME 1, Number: 1 2 3 4 5 6 7 8 9 10 11 12   VOLUME 2, Number: 1 2 3 4 5 6 7 8 9 10 11 12
VOLUME 3, Number: 1 2 3 4 5 6 7 8 9 10 11 12   VOLUME 4, Number: 1 2 3 4 5 6 7 8 9